1558.HK实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (6 May 2024 @ 16:08):

Stats
今日成交量	3.60M
平均成交量	2.19M
市值	11.14B
EPS	HKD0 ( 2024-03-28 )
Last Dividend	HKD0.114 ( 2020-09-29 )
Next Dividend	HKD0 ( N/A )
P/E	5.19
ATR14	HKD0.0140 (0.11%)

音量相关性

長: -0.15 (neutral)

短: -0.64 (weak negative)

Signal:(41.519) Neutral

YiChang HEC ChangJiang 相关性

10 最正相关

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

YiChang HEC ChangJiang 相关性 - 货币/商品

0.26
( neutral )

0.63
( weak )

0.00
( neutral )

-0.59
( weak negative )

0.57
( weak )

0.70
( moderate )

YiChang HEC ChangJiang 财务报表

Annual	2023
营收:	HKD6.29B
毛利润:	HKD4.99B (79.21 %)
EPS:	HKD2.26

FY	2023
营收:	HKD6.29B
毛利润:	HKD4.99B (79.21 %)
EPS:	HKD2.26

FY	2022
营收:	HKD3.74B
毛利润:	HKD2.85B (76.00 %)
EPS:	HKD0.0871

FY	2021
营收:	HKD913.79M
毛利润:	HKD483.70M (52.93 %)
EPS:	HKD-0.667

Financial Reports:

No articles found.

YiChang HEC ChangJiang Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)

YiChang HEC ChangJiang Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 9.24 - good (92.39%) | Divividend Growth Potential Score: 4.12 - Potential for dividend initiation, but uncertain (17.56%)

Information

First Dividend	HKD0.0885	2016-06-08
Last Dividend	HKD0.114	2020-09-29
Next Dividend	HKD0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	9	--
Total Paid Out	HKD2.08	--
Avg. Dividend % Per Year	0.00%	--
Score	3.09	--
Div. Sustainability Score	9.24
Div.Growth Potential Score	4.12
Div. Directional Score	6.68	--

Next Divdend (Est)
(2024-07-24)

HKD0 Estimate 0.00 %

Dividend Stability

0.06 Very Bad

Dividend Score

3.09

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Top 10 dividend Companies for HKSE

Symbol	Title	Last dividend	Frequency	Yearly Dividend
1599.HK	Ex Dividend Junior	2023-05-31	Annually	0.00%
0636.HK	Ex Dividend Knight	2023-09-07	Semi-Annually	0.00%
9982.HK	Ex Dividend Knight	2023-12-12	Semi-Annually	0.00%
2189.HK	Ex Dividend Knight	2023-08-16	Semi-Annually	0.00%
1184.HK	Ex Dividend Knight	2023-09-21	Semi-Annually	0.00%
0251.HK	Ex Dividend Junior	2023-09-20	Semi-Annually	0.00%
3900.HK	Ex Dividend Junior	2023-06-20	Sporadic	0.00%
1760.HK	Ex Dividend Junior	2023-06-01	Annually	0.00%
0798.HK	Ex Dividend Junior	2023-06-20	Annually	0.00%
2343.HK	Ex Dividend Junior	2023-08-11	Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.317	1.500	3.67	5.50	[0 - 0.5]
returnOnAssetsTTM	0.156	1.200	4.79	5.75	[0 - 0.3]
returnOnEquityTTM	0.268	1.500	8.13	10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	1.397	0.800	8.01	6.41	[1 - 3]
quickRatioTTM	0.869	0.800	9.59	7.67	[0.8 - 2.5]
cashRatioTTM	0.387	1.500	8.96	10.00	[0.2 - 2]
debtRatioTTM	0.205	-1.500	6.59	-9.88	[0 - 0.6]
interestCoverageTTM	0	1.000	-1.111	-1.111	[3 - 30]
operatingCashFlowPerShareTTM	1.894	2.00	9.37	10.00	[0 - 30]
freeCashFlowPerShareTTM	1.505	2.00	9.25	10.00	[0 - 20]
debtEquityRatioTTM	0.329	-1.500	8.68	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.792	1.000	0.132	0.132	[0.2 - 0.8]
operatingProfitMarginTTM	0.443	1.000	3.13	3.13	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.641	1.000	7.55	7.55	[0.2 - 2]
assetTurnoverTTM	0.494	0.800	-0.0406	-0.0325	[0.5 - 2]
Total Score				9.24

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	5.16	1.000	9.58	0	[1 - 100]
returnOnEquityTTM	0.268	2.50	8.80	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	1.505	2.00	9.50	10.00	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	1.894	2.00	9.37	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0.0783	1.500	-2.81	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.266	1.000	5.85	0	[0.1 - 0.5]
Total Score				4.12

YiChang HEC ChangJiang

YiChang HEC ChangJiang Pharmaceutical Co., Ltd. develops, manufactures, and sells pharmaceutical products in the therapeutic areas of anti-virus, endocrine and metabolic diseases, and cardiovascular diseases in the People's Republic of China. It also manufactures and sells active pharmaceutical ingredients; researches and develops medical devices and drugs, as well as biotechnology; and provides medical consulting services. The company sells its products to hospitals and medical institutions through a network of distributors. It has a strategic cooperation framework agreement with Alibaba Health Technology (China) Limited to carry out influenza special projects; Jointown Pharmaceutical Group Co., Ltd.; Guangdong Yihao Pharmaceutical Co., Ltd.; and Shenzhen HEC Industrial Development Co., Ltd, as well as strategic cooperative partnership with China National Accord Medicines Corporation Ltd. The company was formerly known as Yichang Changjiang Pharmaceutical Company Limited and changed its name to YiChang HEC ChangJiang Pharmaceutical Co., Ltd. in May 2015. The company was incorporated in 2001 and is based in Yichang, China. YiChang HEC ChangJiang Pharmaceutical Co., Ltd. is a subsidiary of Guangdong HEC Technology Holding Co., Ltd.